These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35154744)

  • 21. Prevalence of SARS-CoV-2 in urban and rural Ethiopia: Randomized household serosurveys reveal level of spread during the first wave of the pandemic.
    Abdella S; Riou S; Tessema M; Assefa A; Seifu A; Blachman A; Abera A; Moreno N; Irarrazaval F; Tollera G; Browning D; Tasew G
    EClinicalMedicine; 2021 May; 35():100880. PubMed ID: 34124630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High SARS-CoV-2 seroprevalence but no severe course of COVID-19 disease among people on opioid agonist treatment in Zurich: a cross-sectional study.
    Bruggmann P; Senn O; Frei A; Puhan MA; Fehr J; Falcato L
    Swiss Med Wkly; 2022 Jan; 152():w30122. PubMed ID: 35019254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2 specific IgG antibodies among participants presenting to a voluntary testing facility in Srinagar, Kashmir.
    Kousar R; Sabah I; Qazi TB; Haq I; Qurieshi MA; Khan SMS
    J Family Med Prim Care; 2022 Jun; 11(6):2667-2671. PubMed ID: 36119315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of SARS-CoV-2 IgG antibodies in an area of northeastern Italy with a high incidence of COVID-19 cases: a population-based study.
    Stefanelli P; Bella A; Fedele G; Pancheri S; Leone P; Vacca P; Neri A; Carannante A; Fazio C; Benedetti E; Fiore S; Fabiani C; Simmaco M; Santino I; Zuccali MG; Bizzarri G; Magnoni R; Benetollo PP; Merler S; Brusaferro S; Rezza G; Ferro A
    Clin Microbiol Infect; 2021 Apr; 27(4):633.e1-633.e7. PubMed ID: 33253941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High SARS-CoV-2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo.
    Batchi-Bouyou AL; Lobaloba Ingoba L; Ndounga M; Vouvoungui JC; Mfoutou Mapanguy CC; Boumpoutou KR; Ntoumi F
    Int J Infect Dis; 2021 May; 106():3-7. PubMed ID: 33370565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The seroprevalence of SARS-CoV-2 in a rural southwest community.
    Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J
    J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 seroprevalence among 7950 healthcare workers in the Region of Southern Denmark.
    von Huth S; Lillevang ST; Røge BT; Madsen JS; Mogensen CB; Coia JE; Möller S; Justesen US; Johansen IS
    Int J Infect Dis; 2021 Nov; 112():96-102. PubMed ID: 34534698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 2020
    Wiens KE; Mawien PN; Rumunu J; Slater D; Jones FK; Moheed S; Caflisch A; Bior BK; Jacob IA; Lako RL; Guyo AG; Olu OO; Maleghemi S; Baguma A; Hassen JJ; Baya SK; Deng L; Lessler J; Demby MN; Sanchez V; Mills R; Fraser C; Charles RC; Harris JB; Azman AS; Wamala JF
    Emerg Infect Dis; 2021 Jun; 27(6):1598-1606. PubMed ID: 34013872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare personnel in the Midwestern United States, September 2020-April 2021.
    Bosserman RE; Farnsworth CW; O'Neil CA; Cass C; Park D; Ballman C; Wallace MA; Struttmann E; Stewart H; Arter O; Peacock K; Fraser VJ; Budge PJ; Olsen MA; Burnham CD; Babcock HM; Kwon JH;
    Antimicrob Steward Healthc Epidemiol; 2023; 3(1):e133. PubMed ID: 37592963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Ethiopian Healthcare Workers.
    Gelanew T; Seyoum B; Mulu A; Mihret A; Abebe M; Wassie L; Gelaw B; Sorsa A; Merid Y; Muchie Y; Teklemariam Z; Tesfaye B; Osman M; Jebessa G; Atinafu A; Hailu T; Habte A; Kenea D; Gadissa A; Admasu D; Tesfaye E; Bates TA; Bulcha J; Tschopp R; Tsehay D; Mullholand K; Howe R; Genetu A; Tafesse FG; Abdissa A
    Res Sq; 2021 Jul; ():. PubMed ID: 34312618
    [No Abstract]   [Full Text] [Related]  

  • 31. Severe acute respiratory syndrome coronavirus 2 seroprevalence survey among 10,256 workers in Kuwait.
    Altawalah H; Alfouzan W; Dhar R; Alali W; Bastaki H; Al-Fadalah T; Al-Ghimlas F; Rabaan AA; Ezzikouri S
    J Clin Virol Plus; 2021 Jun; 1(1):100017. PubMed ID: 35262005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroprevalence of SARS-CoV-2 IgG in blood donors in a teaching institute from Western part of Maharashtra.
    Patil RA; Das NK; Gandham NR; Vyawahare C; Ajagunde J; Khan S; Ratnakar PJ; Ingle Y
    J Family Med Prim Care; 2024 May; 13(5):1701-1707. PubMed ID: 38948624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of Anti-SARS-CoV-2 Antibodies in Poznań, Poland, after the First Wave of the COVID-19 Pandemic.
    Lorent D; Nowak R; Roxo C; Lenartowicz E; Makarewicz A; Zaremba B; Nowak S; Kuszel L; Stefaniak J; Kierzek R; Zmora P
    Vaccines (Basel); 2021 May; 9(6):. PubMed ID: 34064028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seroprevalence of SARS-CoV-2 immunoglobulin G in HIV-positive and HIV-negative individuals in KwaZulu-Natal, South Africa.
    Francois KA; Msomi N; Govender K; Gounder L; Moodley P; Parboosing R; Chetty I; Xaba L; Khan A
    Afr J Lab Med; 2023; 12(1):2065. PubMed ID: 37434993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence in healthcare personnel in northern California early in the coronavirus disease 2019 (COVID-19) pandemic.
    Rosser JI; Röltgen K; Dymock M; Shepard J; Martin A; Hogan CA; Blomkalns A; Mathew R; Parsonnet J; Pinsky BA; Maldonado YA; Boyd SD; Chang SI; Holubar M;
    Infect Control Hosp Epidemiol; 2021 Sep; 42(9):1053-1059. PubMed ID: 33292895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Australia After the First Epidemic Wave in 2020: A National Survey.
    Vette KM; Machalek DA; Gidding HF; Nicholson S; O'Sullivan MVN; Carlin JB; Downes M; Armstrong L; Beard FH; Dwyer DE; Gibb R; Gosbell IB; Hendry AJ; Higgins G; Hirani R; Hueston L; Irving DO; Quinn HE; Shilling H; Smith D; Kaldor JM; Macartney K
    Open Forum Infect Dis; 2022 Mar; 9(3):ofac002. PubMed ID: 35169588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second Wave of the COVID-19 Pandemic in Delhi, India: High Seroprevalence Not a Deterrent?
    Sharma N; Sharma P; Basu S; Bakshi R; Gupta E; Agarwal R; Dushyant K; Mundeja N; Marak Z; Singh S; Singh G; Rustagi R
    Cureus; 2021 Oct; 13(10):e19000. PubMed ID: 34853742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimated Community Seroprevalence of SARS-CoV-2 Antibodies - Two Georgia Counties, April 28-May 3, 2020.
    Biggs HM; Harris JB; Breakwell L; Dahlgren FS; Abedi GR; Szablewski CM; Drobeniuc J; Bustamante ND; Almendares O; Schnall AH; Gilani Z; Smith T; Gieraltowski L; Johnson JA; Bajema KL; McDavid K; Schafer IJ; Sullivan V; Punkova L; Tejada-Strop A; Amiling R; Mattison CP; Cortese MM; Ford SE; Paxton LA; Drenzek C; Tate JE;
    MMWR Morb Mortal Wkly Rep; 2020 Jul; 69(29):965-970. PubMed ID: 32701941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of SARS-CoV-2 antibodies among North Dakota community pharmacy personnel: A seroprevalence survey.
    Johnson A; Vincent B; Carson P; Skoy E
    J Am Pharm Assoc (2003); 2021; 61(3):e127-e132. PubMed ID: 33568267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
    Saeed S; Drews SJ; Pambrun C; Yi QL; Osmond L; O'Brien SF
    Transfusion; 2021 Mar; 61(3):862-872. PubMed ID: 33527398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.